While managing these factors, its also important to consider how your skin and overall health might contribute
In contrast to other weekly-administered GLP-1 receptor agonists, it must be injected daily a schedule that might not be as convenient for some individuals
In these two Phase 3 studies (n=3,680 total), patients are randomized to placebo or oral semaglutide in a 1:1 ratio and assessed using the CDR-SB at 2 years, with follow-up of up to 3 years
We are working with our partners to continually review and improve the results
3163) was created in December 2025 for claims that Ozempic use caused NAION (an eye stroke that can cause vision loss)
Last reviewed: May 16, 2026 Last updated: May 16, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations